Results 51 to 60 of about 294,878 (304)

Cost-Effectiveness of COVID-19 Sequential Vaccination Strategies in Inactivated Vaccinated Individuals in China

open access: yesVaccines, 2022
To effectively prevent and control the COVID-19 pandemic, countries have adopted a booster vaccination strategy. This study aimed to estimate the cost-effectiveness of sequential booster COVID-19 vaccination compared to two-dose inactivated vaccination ...
Yaqun Fu   +7 more
doaj   +1 more source

Assessment of Health and Nutritional Status Under the Integrated Child Development Services: in the Field Practice Area of Rural Training Health Centre, Nadayara, Travancore Medical College, Kollam-India [PDF]

open access: yes, 2013
Assessment of health and nutritional status was carried out in Anganwadi Children in the Field Practice Area of Rural Training Health Centre, Nadayara, Travancore Medical College, Kollam.
Abraham, A. J. (and), Sumit, D. (D)
core  

Correlation between Anti-SARS-CoV-2 Total Antibodies and Spike Trimeric IgG after BNT162b2 Booster Immunization

open access: yesVaccines, 2022
Objective: In this work we monitored both total and IgG anti-SARS-CoV-2 antibodies responses after BNT162b2 vaccine booster immunization in a cohort of ostensibly healthy healthcare workers. Methods: The study population consisted of 266 subjects (median
Gian Luca Salvagno, Giuseppe Lippi
doaj   +1 more source

Launch Vehicle Description [PDF]

open access: yes, 1970
The Thorad-Agena is a two-stage launch vehicle consisting of a Thorad first-stage and an Agena second-stage, connected by a booster adapter. The composite vehicle, including the shroud and the booster adapter, is about 33 meters (109 ft) long.
Coffey, E. E., Geye, R. P.
core   +1 more source

Adherence to Protocol Recommendations for Children With Wilms Tumour in Two Consecutive Studies in the United Kingdom and Ireland—Does Variation Matter?

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background and Aims Wilms tumour (WT) has excellent event‐free and overall survival (OS). However, small differences exist between countries participating in the same international study. This led us to examine variation in adherence to protocol recommendations as a potential contributing factor.
Suzanne Tugnait   +23 more
wiley   +1 more source

Seroproteksi Antibodi Anti-pertusis pada anak usia 6 - 7 Tahun dengan Riwayat Vaksinasi DTP Dasar Lengkap dan Ulangan di Sekolah Dasar di Jakarta

open access: yesSari Pediatri, 2016
Latar belakang. Angka kejadian pertusis semakin meningkat selama dua dekade terakhir walaupun cakupan vaksinasi DTP sudah cukup tinggi. Peningkatan insidens kasus pertusis terutama terlihat pada usia remaja dan dewasa, sehingga menjadi sumber penular ...
Runi Deasiyanti
doaj   +1 more source

COVID-19 Vaccine Booster: To Boost or Not to Boost

open access: yesInfectious Disease Reports, 2021
Developing safe and effective vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at a breakneck speed has been an exceptional human achievement.
Rahul Shekhar   +4 more
doaj   +1 more source

Orbiter/launch system [PDF]

open access: yes, 1981
The system includes reusable turbojet propelled booster vehicles releasably connected to a reusable rocket powered orbit vehicle. The coupled orbiter-booster combination takes off horizontally and ascends to staging altitude and speed under booster power
Jackson, L. R.   +3 more
core   +1 more source

The Boosters in Boosterism: Some Calgary Examples [PDF]

open access: yesUrban History Review, 1979
Through an examination of four Calgary boosters in the pre-1914 period, this article argues that boosterism in the prairie west was largely institutional. The rhetoric of progress was proclaimed loudest in publications produced by business organizations and political bodies.
openaire   +1 more source

Sirolimus for Extracranial Arteriovenous Malformations: A Scoping Review of the Evidence in Syndromic and Non‐Syndromic Cases

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Arteriovenous malformations (AVMs) are rare, high‐flow, vascular anomalies that can occur either sporadically or as part of a genetic syndrome. AVMs can progress with serious morbidity and even mortality if left unchecked. Sirolimus is an mTOR inhibitor that is effective in low‐flow vascular malformations; however, its role in AVMs is unclear.
Will Swansson   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy